Table 1. Characteristics of the study subjects.
| Clinicopathologic features | Number | Percentage (%) |
|---|---|---|
| Age (years) | ||
| <60 | 62 | 34.4 |
| ≥60 | 118 | 65.6 |
| Gender | ||
| male | 130 | 72.2 |
| female | 50 | 17.8 |
| Tumour Size (cm) | ||
| <10 | 156 | 86.7 |
| ≥10 | 24 | 23.3 |
| Tumour site | ||
| cardia | 26 | 14.4 |
| Non-cardia | 154 | 85.6 |
| Pathological type | ||
| adenocarcinoma | 176 | 97.8 |
| undifferentiated carcinoma | 4 | 2.2 |
| Tumour status | ||
| T1+T2 | 24 | 13.4 |
| T3+T4 | 155 | 86.6 |
| Nodal status | ||
| negative | 45 | 25.0 |
| positive | 135 | 75.0 |
| Metastasis status | ||
| M0 | 166 | 92.2 |
| M1 | 14 | 7.8 |
| Tumour stage | ||
| I | 17 | 9.4 |
| II | 56 | 31.1 |
| III | 92 | 51.1 |
| IV | 14 | 7.8 |
| Follow-up time (months) | 79.2-97.2 | |
| Prognosis | ||
| alive | 49 | 25.8 |
| dead | 125 | 74.2 |
| patients lived for ≥5 years | 74 | 41.1 |
| patients lived for <5 years | 106 | 58.9 |